VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SRTS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SRTSSensus Healthcare, Inc.
$2.26$37M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSRTSFinancials

Sensus Healthcare, Inc. (SRTS) Income Statement

12Y historyFree accessUpdated daily

Revenue has contracted significantly alongside gross margin compression, which fell from a peak of 62.5% in 2024Q1 to 29.2% in 2026Q1.

Income StatementBalance SheetCash FlowRatios

SRTS Income Statement

Annual statement

SRTS Income Statement

Sensus Healthcare, Inc. (SRTS) annual income statement — 12-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Sales/Revenue16.62M27.48M41.81M24.41M44.53M27.04M9.58M27.26M26.43M20.59M14.81M10.27M5.81M
Revenue Growth %-53.33%-34.26%71.31%-45.2%64.68%182.36%-64.87%3.16%28.36%39%44.17%76.81%-
Cost of Goods Sold9.67M15.62M17.38M10.35M14.9M10.05M4.33M9.71M9.52M6.79M4.97M3.7M2.05M
COGS % of Revenue-56.82%41.56%42.39%33.47%37.18%45.19%35.6%36.01%32.97%33.52%36%35.37%
Gross Profit6.95M11.87M24.43M14.06M29.63M16.99M5.25M17.56M16.91M13.8M9.85M6.57M3.76M
Gross Margin %41.8%43.18%58.44%57.61%66.53%62.82%54.81%64.4%63.99%67.03%66.48%64%64.63%
Gross Profit Growth %--51.43%73.76%-52.54%74.41%223.64%-70.1%3.82%22.54%40.16%49.76%75.07%-
Operating Expenses19.25M22.17M16.34M14.44M14.8M12.87M13.48M19.53M18.92M17.52M10.21M6.8M7.44M
OpEx % of Revenue-80.69%39.09%59.18%33.23%47.59%140.79%71.62%71.58%85.09%68.93%66.15%127.98%
Selling, General & Admin13.56M14.4M12.13M10.76M11.34M9.43M9.32M13.11M12.66M12.03M8.38M5.33M5.86M
SG&A % of Revenue-52.38%29%44.11%25.46%34.88%97.37%48.08%47.89%58.42%56.61%51.87%100.84%
Research & Development5.69M7.78M4.22M3.68M3.46M3.44M4.16M6.42M6.26M5.49M1.82M1.47M1.58M
R&D % of Revenue-28.3%10.08%15.07%7.77%12.71%43.42%23.54%23.69%26.67%12.32%14.28%27.14%
Other Operating Expenses0000000000000
Operating Income-12.31M-10.31M8.09M-382K14.83M4.12M-8.23M-1.97M-2.01M-3.72M-363.12K-221.26K-3.68M
Operating Margin %-74.05%-37.5%19.35%-1.57%33.3%15.24%-85.98%-7.22%-7.59%-18.06%-2.45%-2.15%-63.34%
Operating Income Growth %--227.4%2217.8%-102.58%259.98%150.04%-318.33%1.85%46.06%-923.75%-64.12%93.99%-
EBITDA-11.76M-9.68M8.52M79K15.34M4.73M-7.51M-1.42M-1.35M-3.33M-25.54K94.34K-3.41M
EBITDA Margin %-70.74%-35.23%20.38%0.32%34.45%17.5%-78.44%-5.22%-5.1%-16.17%-0.17%0.92%-58.65%
EBITDA Growth %-143.09%-213.6%10687.34%-99.48%224.11%163.01%-428.06%-5.6%59.54%-12938.55%-127.07%102.77%-
D&A (Non-Cash Add-back)550K626K432K461K509K613K722K545.72K658.25K387.92K337.58K315.6K272.65K
EBIT-11.9M-9.62M9.02M652K27.99M4.12M-6.82M-1.7M-1.87M-3.64M-324.58K-219.48K-3.68M
Net Interest Income524K683K932K992K380K1K52K268.29K-17.41K6.93K16.67K-16.01K-19.21K
Interest Income524K683K932K992K382K2K66K268.29K139.28K75.81K38.54K1.78K820
Interest Expense00002K1K14K0156.69K68.88K21.87K17.79K20.03K
Other Income/Expense524K683K932K1.03M13.16M-1K1.4M268.29K-17.41K6.93K16.67K-16.01K-19.21K
Pretax Income-11.78M-9.62M9.02M652K27.99M4.12M-6.84M-1.7M-2.02M-3.71M-346.45K-237.27K-3.7M
Pretax Margin %-70.9%-35.02%21.58%2.67%62.85%15.23%-71.38%-6.24%-7.65%-18.02%-2.34%-2.31%-63.67%
Income Tax4.25M-1.91M2.38M167K3.75M0000001.78K820
Effective Tax Rate %-36.1%19.79%26.32%25.61%13.38%0%0%0%0%0%0%-0.75%-0.02%
Net Income-16.04M-7.72M6.65M485K24.24M4.12M-6.84M-1.7M-2.02M-3.71M-346.45K-237.27K-3.7M
Net Margin %-96.49%-28.09%15.9%1.99%54.44%15.23%-71.38%-6.24%-7.65%-18.02%-2.34%-2.31%-63.67%
Net Income Growth %-433.43%-216.13%1270.52%-98%488.59%160.25%-302.12%15.96%45.49%-971.02%-46.02%93.59%-
Net Income (Continuing)-16.04M-7.72M6.65M485K24.24M4.12M-6.84M-1.7M-2.02M-3.71M-346.45K-237.27K-3.7M
Discontinued Operations0000000000000
Minority Interest0000000000000
EPS (Diluted)-0.97-0.470.410.031.460.25-0.42-0.07-0.14-0.28-0.03-0.02-0.37
EPS Growth %-417.89%-214.63%1275.84%-97.96%484%159.52%-490.72%49.21%50%-872.22%-30.91%94.05%-
EPS (Basic)--0.470.410.031.470.25-0.42-0.07-0.14-0.28-0.03-0.02-0.37
Diluted Shares Outstanding16.46M16.33M16.36M16.27M16.62M16.5M16.43M16.23M14.12M13.24M12.03M10.78M9.89M
Basic Shares Outstanding16.46M16.33M16.31M16.26M16.48M16.48M16.43M16.23M14.12M13.24M12.03M10.78M9.88M
Dividend Payout Ratio-------------

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Reimbursement and sales volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Contraction Reflects Sales Headwinds

As reported in recent financial filings, Sensus Healthcare experienced a severe revenue decline, with top-line figures falling to $3.4M in 2026Q1 from $12.6M in 2023Q4, representing a sustained period of negative growth that suggests significant challenges in maintaining the company's capital equipment sales cycle.

The consistent quarter-over-quarter revenue decay indicates that the company's primary sales funnel for SRT-100 units is facing substantial friction. This trend suggests that the high-ticket nature of the equipment may be increasingly sensitive to the current macroeconomic environment and private practice capital expenditure constraints.

Gross Margin Erosion Signals Pricing

Based on the company's quarterly income statements, gross margins have compressed from a peak of 62.5% in 2024Q1 to 29.2% in 2026Q1, indicating that Sensus is struggling to maintain pricing power or manage rising component costs amidst a shrinking installed base of active medical devices.

The sharp deterioration in gross margin suggests that the company may be forced to offer deeper discounts to move inventory or that the mix of revenue has shifted toward lower-margin service offerings. Investors should monitor whether this margin compression is structural or a temporary reaction to competitive pricing pressures.

Operating Deleveraging Strains Financial Health

According to the provided income statement data, Sensus has transitioned from an operating profit of $5.6M in 2023Q4 to an operating loss of $4.4M in 2026Q1, demonstrating a clear case of operating deleveraging where fixed costs are outpacing the company's ability to generate gross profit.

The inability to scale SG&A and R&D expenses relative to declining revenue suggests that the current cost structure is misaligned with the company's reduced operational scale. This trend implies that without a significant revenue inflection, the company may continue to burn through its cash reserves to sustain its current overhead.

Sustainability of Current Business Model

While the company maintains a clean balance sheet with minimal debt, the persistent negative net income, which reached -$2.6M in 2026Q1, warrants further investigation into whether the current business model can achieve profitability before the existing cash cushion is exhausted by ongoing operational losses.

Short-term observers may focus on the risk that the company's reliance on capital equipment sales is fundamentally incompatible with the current market environment. The lack of a clear path to positive operating margins suggests that the company's long-term viability may depend on a pivot toward a more predictable, recurring revenue model.

SRTS — Frequently Asked Questions

Quick answers to the most common questions about buying SRTS stock.

What was Sensus Healthcare, Inc.'s (SRTS) revenue in 2025?

For fiscal year 2025, Sensus Healthcare, Inc. (SRTS) reported total revenue of $27.5M. This represents a 373.0% increase compared to $5.8M in 2014.

Is Sensus Healthcare, Inc. (SRTS) profitable?

Sensus Healthcare, Inc. (SRTS) reported a net loss of $7.7M for the fiscal year ending 2025.

What is Sensus Healthcare, Inc.'s operating profit margin?

Sensus Healthcare, Inc. (SRTS) reported an operating income of $-10.3M, resulting in an operating profit margin of -37.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Sensus Healthcare, Inc.'s gross profit and gross margin?

Sensus Healthcare, Inc. (SRTS) generated $11.9M in gross profit for the year, representing a gross profit margin of 43.2%. This demonstrates the company's core pricing power and production efficiency.